RAFAEL HOLDINGS, INC. Related Party Transaction, Expenses from Transactions with Related Party
RAFAEL HOLDINGS, INC. (RFL) reported Related Party Transaction, Expenses from Transactions with Related Party of $20.00 thousand for the 3-month period ending 2023-01-31, per its 10-Q filed 2023-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty · last filed 2023-03-14
- RAFAEL HOLDINGS, INC. related party transaction, expenses from transactions with related party for the quarter ending 2023-01-31 was $20.00K, a 75.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. related party transaction, expenses from transactions with related party for the quarter ending 2022-10-31 was $68.00K, a 9.33% decline year-over-year.
- RAFAEL HOLDINGS, INC. related party transaction, expenses from transactions with related party for the quarter ending 2022-07-31 was $95.00K, a 26.67% increase year-over-year.
- RAFAEL HOLDINGS, INC. related party transaction, expenses from transactions with related party for the quarter ending 2022-04-30 was $92.00K, a 1.10% increase year-over-year.
- RAFAEL HOLDINGS, INC. related party transaction, expenses from transactions with related party for fiscal 2022 was $343.00K, a 6.52% increase from fiscal 2021.
- RAFAEL HOLDINGS, INC. related party transaction, expenses from transactions with related party for fiscal 2021 was $322.00K, a 4.21% increase from fiscal 2020.
- RAFAEL HOLDINGS, INC. related party transaction, expenses from transactions with related party for fiscal 2020 was $309.00K.
- RAFAEL HOLDINGS, INC. related party transaction, expenses from transactions with related party for fiscal 2018 was $385.00K, a 61.23% decline from fiscal 2017.
| Period end | Related Party Transaction, Expenses from Transactions with Related Party 3 month | Related Party Transaction, Expenses from Transactions with Related Party 6 month | Related Party Transaction, Expenses from Transactions with Related Party 6 month as first filed | Related Party Transaction, Expenses from Transactions with Related Party 9 month | Related Party Transaction, Expenses from Transactions with Related Party 12 month |
|---|---|---|---|---|---|
| 2023-01-31 | $20.00K 10-Q · filed 2023-03-14 | $88.00K 10-Q · filed 2023-03-14 | $183.00K derived: sum of 3 quarters · filed 2023-03-14 | $275.00K derived: sum of 4 quarters · filed 2023-03-14 | |
| 2022-10-31 | $68.00K 10-Q · filed 2022-12-13 | $163.00K derived: sum of 2 quarters · filed 2022-12-13 | $255.00K derived: sum of 3 quarters · filed 2022-12-13 | $335.00K derived: sum of 4 quarters · filed 2023-03-14 | |
| 2022-07-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $187.00K derived: sum of 2 quarters · filed 2022-10-31 | $267.00K derived: sum of 3 quarters · filed 2023-03-14 | $343.00K 10-K · filed 2022-10-31 | |
| 2022-04-30 | $92.00K 10-Q · filed 2022-06-14 | $172.00K derived: sum of 2 quarters · filed 2023-03-14 | $248.00K 10-Q · filed 2022-06-14 | $322.00K derived: sum of 4 quarters · filed 2023-03-14 | |
| 2022-01-31 | $80.00K 10-Q · filed 2023-03-14 | $156.00K 10-Q · filed 2023-03-14 | $230.00K derived: sum of 3 quarters · filed 2023-03-14 | $321.00K derived: sum of 4 quarters · filed 2023-03-14 | |
| 2021-10-31 | $75.00K 10-Q · filed 2022-12-13 | $150.00K derived: sum of 2 quarters · filed 2022-12-13 | $241.00K derived: sum of 3 quarters · filed 2022-12-13 | $331.00K derived: sum of 4 quarters · filed 2022-12-13 | |
| 2021-07-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $166.00K derived: sum of 2 quarters · filed 2022-10-31 | $256.00K derived: sum of 3 quarters · filed 2022-10-31 | $322.00K 10-K · filed 2022-10-31 | |
| 2021-04-30 | $91.00K 10-Q · filed 2022-06-14 | $181.00K derived: sum of 2 quarters · filed 2022-06-14 | $247.00K 10-Q · filed 2022-06-14 | $324.00K derived: sum of 4 quarters · filed 2022-06-14 | |
| 2021-01-31 | $90.00K 10-Q · filed 2022-03-17 | $155.00K 10-Q · filed 2022-03-17 | $90.00K 10-Q · filed 2021-03-17 | $233.00K derived: sum of 3 quarters · filed 2022-03-17 | $309.00K derived: sum of 4 quarters · filed 2022-03-17 |
| 2020-10-31 | $66.00K 10-Q/A · filed 2022-02-28 | $143.00K derived: sum of 2 quarters · filed 2022-02-28 | $219.00K derived: sum of 3 quarters · filed 2022-02-28 | ||
| 2020-07-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | $153.00K derived: sum of 2 quarters · filed 2021-10-18 | $309.00K 10-K · filed 2021-10-18 | ||
| 2020-04-30 | $76.00K 10-Q · filed 2021-06-14 | $232.00K 10-Q · filed 2021-06-14 | |||
| 2019-01-31 | $35.00K 10-Q · filed 2019-03-12 | $109.00K derived: sum of 2 quarters · filed 2019-03-12 | $109.00K derived: sum of 3 quarters · filed 2019-03-12 | $58.00K derived: sum of 4 quarters · filed 2019-03-12 | |
| 2018-10-31 | $74.00K 10-Q · filed 2019-03-12 | $74.00K derived: sum of 2 quarters · filed 2019-03-12 | $23.00K derived: sum of 3 quarters · filed 2019-03-12 | ||
| 2018-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | -$51.00K derived: sum of 2 quarters · filed 2018-10-15 | $385.00K 10-K · filed 2018-10-15 | ||
| 2018-04-30 | -$51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-06-11 | $385.00K 10-Q · filed 2018-06-11 | |||
| 2018-01-31 | $436.00K 10-Q · filed 2018-03-12 | ||||
| 2017-07-31 | $290.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15 | $522.00K derived: sum of 2 quarters · filed 2018-10-15 | $993.00K 10-K · filed 2018-10-15 | ||
| 2017-04-30 | $232.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-06-11 | $703.00K 10-Q · filed 2018-06-11 | |||
| 2017-01-31 | $471.00K 10-Q · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |